We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The effect of maintaining high hemoglobin levels on long-term kidney function in kidney transplant recipients: a randomized controlled trial.
- Authors
Tsujita, Makoto; Kosugi, Tomoki; Goto, Norihiko; Futamura, Kenta; Nishihira, Morikuni; Okada, Manabu; Hiramitsu, Takahisa; Narumi, Shunji; Uchida, Kazuharu; Takeda, Asami; Morozumi, Kunio; Maruyama, Shoichi; Watarai, Yoshihiko
- Abstract
Background Posttransplant anemia may be a major determinant of chronic allograft nephropathy. However, the impact of correcting anemia on graft function remains controversial. Methods A 3-year follow-up of an open-label, multicenter, randomized controlled trial involving kidney transplantation recipients examined whether sustained maintenance of target hemoglobin (Hb) concentrations at a high level (12.5–13.5 g/dL, n = 64) with either darbepoetin alfa or epoetin beta pegol would slow the graft function decline rate as the primary efficacy endpoint, compared with maintenance of a low Hb concentration (10.5–11.5 g/dL, n = 63). Results The mean blood pressures in the two groups were well controlled throughout the study. In the high Hb group, mean Hb concentrations increased to >12 g/dL at 3 months, reaching the target range at 18 months. At the end of this study (36 months), the mean Hb concentration was 12.8 ± 0.7 g/dL in the high Hb group and 11.5 ± 1.2 g/dL in the low Hb group. The decline rate of the estimated glomerular filtration (eGFR) rate was considerably greater in the low Hb group (ΔeGFR, −5.1 ± 9.5 mL/min/1.73 m2) than in the high Hb group (−1.0 ± 8.4 mL/min/1.73 m2) (P = 0.02). Of note, only a few high Hb patients developed cardiovascular events and returned to hemodialysis, but the low Hb patients did not. Conclusion This prospective study suggests that correcting anemia to the target Hb level range (12.5–13.5 g/dL) slows renal function deterioration by >3 years in the chronic phase of allograft nephropathy.
- Subjects
RANDOMIZED controlled trials; KIDNEY transplantation
- Publication
Nephrology Dialysis Transplantation, 2019, Vol 34, Issue 8, p1409
- ISSN
0931-0509
- Publication type
Article
- DOI
10.1093/ndt/gfy365